“Safety and Efficacy of Bivalirudin in Diabetic Acute Coronary Syndrome (ACS) Patients Undergoing Percutaneous Coronary Intervention (PCI)”, EJMED, vol. 3, no. 2, pp. 93–97, Apr. 2021, doi: 10.24018/ejmed.2021.3.2.768.